Plate-Rich Plasma and its Utility in Clinical Conditions: A Systematic Review

  • Saurabh Khare R&D, SAR CelluLabs Pvt. Ltd, Gurgaon, Haryana 122015, India
  • Shruti Shrirang Dal R&D, SAR CelluLabs Pvt. Ltd, Gurgaon, Haryana 122015, India
  • Suresh Lingam R&D, CellCure Therapeutics, Madurai, Tamil Nadu 625007, India
  • V Veeramanikandan PG & Research Centre in Microbiology, MGR College, Hosur, TN 635109, India
  • Paulraj Balaji PG & Research Centre in Biotechnology, MGR College, Hosur, TN 635109, India
  • Anil Hota R&D, SAR CelluLabs Pvt. Ltd, Gurgaon, Haryana 122015, India
  • Jaianand Kannaiyan R&D, SAR CelluLabs Pvt. Ltd, Gurgaon, Haryana 122015, India

Abstract

Platelet-rich plasma (PRP) is an autologous product derived from whole blood through the process of density gradient centrifugation which contains a concentrated form of a large number of platelets in a small volume of plasma. PRP has a higher concentration of growth factors than whole blood. These growth factors promote natural healing. PRP is becoming more popular as a treatment option for a broad spectrum of medical disorders. PRP has been studied but has received less attention. The objective of this literature review was to focus on the utility of PRP on various medical conditions and, to consolidate the available evidence on PRP for the practicing dermatological conditions.


Keywords: Pure Platelet-Rich Plasma (P-PRP), Leukocyte-and Platelet-Rich Plasma (L-PRP), Red - Platelet-Rich Plasma (R-PRP), Injectable Platelet Rich Fibrin (i-PRF), Platelet-rich plasma (PRP), Platelet-poor plasma (PPP), Cytokines, Growth factors.

Keywords: Pure Platelet-Rich Plasma (P-PRP), Leukocyte-and Platelet-Rich Plasma (L-PRP), Red - Platelet-Rich Plasma (R-PRP), Injectable Platelet Rich Fibrin (i-PRF), Platelet-rich plasma (PRP), Platelet-poor plasma (PPP), Cytokines, Growth factors

Downloads

Download data is not yet available.

Author Biographies

Saurabh Khare, R&D, SAR CelluLabs Pvt. Ltd, Gurgaon, Haryana 122015, India

R&D, SAR CelluLabs Pvt. Ltd, Gurgaon, Haryana 122015, India

Shruti Shrirang Dal, R&D, SAR CelluLabs Pvt. Ltd, Gurgaon, Haryana 122015, India

R&D, SAR CelluLabs Pvt. Ltd, Gurgaon, Haryana 122015, India

Suresh Lingam, R&D, CellCure Therapeutics, Madurai, Tamil Nadu 625007, India

R&D, CellCure Therapeutics, Madurai, Tamil Nadu 625007, India

V Veeramanikandan, PG & Research Centre in Microbiology, MGR College, Hosur, TN 635109, India

PG & Research Centre in Microbiology, MGR College, Hosur, TN 635109, India

Paulraj Balaji, PG & Research Centre in Biotechnology, MGR College, Hosur, TN 635109, India

PG & Research Centre in Biotechnology, MGR College, Hosur, TN 635109, India

Anil Hota, R&D, SAR CelluLabs Pvt. Ltd, Gurgaon, Haryana 122015, India

PRP Division, Qualicells (A unit of SAR Cellulabs Pvt Ltd), Gurugram, Haryana 122015, India.

Jaianand Kannaiyan, R&D, SAR CelluLabs Pvt. Ltd, Gurgaon, Haryana 122015, India

R&D, SAR CelluLabs Pvt. Ltd, Gurgaon, Haryana 122015, India

R&D, CellCure Therapeutics, Madurai, Tamil Nadu 625007, India

PRP Division, Qualicells (A unit of SAR Cellulabs Pvt Ltd), Gurugram, Haryana 122015, India.

References

1. David DE, Isabel A, Matthias AZ, Chang QZ, Nelson RP, Tomasz B, Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopaedic and sports medicine: current consensus, clinical implications, and perspectives, Muscle, Ligaments and Tendons Journal, 2014; 4(1):3-9.
2. Hong BP, Jeong HY, Kwang HC, Characterization of the cytokine profile of platelet-rich plasma (PRP) and PRP-induced cell proliferation and migration: Upregulation of matrix metalloproteinase-1 and -9 in HaCaT cells, The Korean Journal of Hematology, 2011; (46):265-73.
3. Alberto CP, Eliane A, Daniella ZB, Luiz RS, Carlos VA, Mario F, Benno E, Anna CG, Moises C, Analysis of cytokine profile and growth factors in platelet-rich plasma obtained by open systems and commercial columns, Einstein (Sao Paulo), 2016; 14(3):391-397.
4. Hideo M, Toshimitsu O, Taisuke W, Masashi S, Kazuhiko N, Hajime O, Koh N, Kohya U, Chen YS, Tomoyuki K, Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF), International Journal of Implant Dentistry, 2016; 2(1):19.
5. Mersedeh T, Andreas B, Biljana R, Jennifer VH, Nisreen K, Athanassios F, Tolga TS, Holger J, Thomas P, Sebastian L, Platelet-Released Growth Factors Modulate the Secretion of Cytokines in Synoviocytes under Inflammatory Joint Disease, Mediators of Inflammation (Hindawi), 2017; (1):377-87.
6. Kyu CN, Xiao NL, Zhong Z, Cheol JY, Yong TK, Geun WL, Kyung HC, and Kyung OK, Leukocyte-Poor Platelet-Rich Plasma-Derived Growth Factors Enhance Human Fibroblast Proliferation in Vitro, Clinics in Orthopedic Surgery, 2018; 10(2):240–247.
7. What is PRP? Guide to platelet rich plasma treatments. Regenexx Procedure Network. 1-7.
8. Shan ZW, Wei MF, Jun J, Liang YM, Jia BY and Chen W, Is exclusion of leukocytes from platelet-rich plasma (PRP) a better choice for early intervertebral disc regeneration? Stem cell Research & Therapy, 2018; (9):199.
9. Michael J and Hesseler, Platelet-rich plasma and its utility in medical dermatology: A systematic review, Journal of the American Academy of Dermitology, 2019; 81(3):834-846.
10. Marques LF, Stessuk T, Camargo IC, Sabeh JN, Dos SL, Ribeiro JT, Platelet-rich plasma (PRP): Methodological aspects and clinical Platelets, Platelets, 2015; 26(2):101-13.
11. Simental M, Vilchez C, Pena M, Said F, Lara A, Martinez R , Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis, Archives of Orthopaedic and Trauma Surgery, 2016; 136(12):1723-1732.
12. Ting Y, Shang CG, Pei H, Chang QZ, Bing FY, Applications of Leukocyte- and Platelet-Rich Plasma (L-PRP) in Trauma Surgery, Current Pharmaceutical Biotechnology, 2012; 13(7):1173-84.
13. Private Reform; 2021. Available at: http://sarcellulabs.com/lbprp/ Accessed January 31, 2021.
14. Sercan G, Arin O, Veysel B, Erkan K, Effect of Injectable Platelet-Rich Fibrin on Diced Cartilage’s Viability in Rhinoplasty, Facial Plastic & Reconstructive Surgery, 2019; 35(04):393-396.
15. Shahram G, Sarah AM, Yvonne S, Robert S, Joseph C, Cleopatra N, Application of Liquid Platelet‑rich Fibrin for Treating Hyaluronic Acid‑related Complications: A Case Report with 2 Years of Follow up, Cells in dentistry, 2018; 1(2):74:77.
16. Agata CA, Choukroun J, Odin G, Dohan DM, L-PRP/L-PRF in Esthetic Plastic Surgery, Regenerative Medicine of the Skin and Chronic Wounds, Current Pharmaceutical Biotechnology, 2012; 13(7):1266-77.
17. Ritika A and Sagrika S, Injectable-Platelet-Rich Fibrin-Smart Blood with Stem Cells for the Treatment of Alopecia: A Report of Three Patients, International Journal of Trichology, 2019; 11(3):128:131.
18. Nikil KJ and Minkle G, Platelet-rich plasma: a healing virtuoso, Blood Research, 51(1):3–5.
19. Erminia M, Alice R, Luca C, Lia P, Elisa A, Gopal, Shankar K, Annarita C, Elizaveta K, Giuseppe F, Release kinetic of pro-and anti-inflammatory biomolecules from platelet-rich plasma and functional study on osteoarthritis synovial fibroblasts, Cytotherapy, 2020; 22(7):344-353.
20. Erminia M, Valentina C, Luca C, Elizaveta K, Maurilio M, Berardo DM, Lia P, Giuseppe F, Leukocyte-Rich Platelet-Rich Plasma Injections Do Not Up-Modulate Intra-Articular Pro-Inflammatory Cytokines in the Osteoarthritic Knee, PLoS One, 2018; 11(6):3.
21. Nancy MH, Cytokines in Platelet Concentrates, Hematology, 2016; 2(6):473-484.
22. Koob TJ, Lim JJ, Zabek N, Massee M, Cytokines in single layer amnion allografts compared to multilayer amnion/chorion allografts for wound healing, Journal of Biomedical Materials Research Part B applied Biomaterials, 2015; 103(5):1133-40.
23. Lynch SE, Nixon JC, Colvin RB, and Antoniades HN, Role of platelet‐derived growth factor in wound healing: synergistic effects with other growth factors, Proceedings of the National Academy of Sciences, 1986; 84(21):7696–7700.
24. Paola RA, Rosana B, Vieira C, Marcus VT, Italo CP, Ronaldo JA, Jose MG, and Radovan B, Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors, Stem Cell Research and Therapy, 2013; 4(3):67.
25. Liwen C, Edward E. Tredget, Philip YG, Yaojiong W, Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing, PLoS One, 2008; 3(4):1886.
26. Werner S and Grose R, Regulation of wound healing by growth factors and cytokines, Physiological Reviews - American Journal of Physiology, 2003; 83(3):835‐870.
27. Tomoyuki K, Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: basic principles and concepts underlying recent advances, Odontology, 2015; 103(2):126-35.
28. Giovanni V, Giuseppe P, Maria V, and Leo JH, Role of IGF-1 System in the Modulation of Longevity: Controversies and New Insights from a Centenarians Perspective, Front Endocrinol (Lausanne), 2019; 10:27.
29. Eizaburo K, Laura F, Masako FK, Kosaku S, Anton S, Benoit S, Richard JM, Comparative release of growth factors from PRP, PRF, and advanced-PRF, Clinical Oral Investigations, 2016 ;20 (9):2353-2360.
30. Stephan B, Olivera S, Michael SG, Harold B, Marjana TC, Growth factors and cytokines in wound healing, Wound Repair and Regeneration, 2008; 16(5):585‐601.
31. Moyassar B, Shaibani AL, Xiao NW, Penny E. Lovat and Anne MD, Cellular therapy for wounds: Applications of mesenchymal stem cells in wound healing, Wound healing-New insights into Ancient Challenges, 2016; (5).
32. Elena RC, Catriona C, Jonjo M, Licia M, Sarah AA, Nancy J, Rothwell CM, Kielty SM, Allan and Emmanuel P, Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro, Stem Cell Research & Therapy, 2017; 8(1):79.
33. Winifred B, Gimano, Amatngalim, Yvonne ME, Jaap O, Helene R, Christian T, Jan S and Pieter S, TNF-α and IL-1β-activated human mesenchymal stromal cells increase airway epithelial wound healing in vitro via activation of the epidermal growth factor receptor, Respiratory Research, 2016; 17:3.
34. Tamama K and Kerpedjieva SS, Acceleration of wound healing by multiple growth factors and cytokines secreted from multipotential stromal cells/mesenchymal stem cells, Advance in Wound Care (New Rochelle), 2012; 1(4):177‐182.
35. Hocking AM and Gibran NS, Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair, Experimental Cell Research, 2010; 316(14):2213‐2219.
36. Scott M, Erasmo A. Lopez, Dana Y, Alla DM, and Michelle A, Concise review: role of mesenchymal stem cells in wound repair, Stem Cells Translationals Medicine, 2012; 1(2):142‐149.
37. Min Z, Li S, Xueer W, Shixuan C, Yanan K, Nuyun L, Yinghua C, Qin J, Lu Z, Lin Z, Activin B promotes BM‐MSC‐mediated cutaneous wound healing by regulating cell migration via the JNK‐ERK signaling pathway,Cell Transplant, 2013; 23(9):1061-1073.
38. Vries JE, The role of IL-13 and its receptor in allergy and inflammatory responses, Journal of Allergy and Clinical Immunology, 1998; 102(2):165-9.
39. Chae WP, Keun SK, Sohyun B, Hye KS, Pyung KM, Hyo JH, Hoeon K, Cytokine secretion profiling of human mesenchymal stem cells by antibody array, International Journal of Stem Cells, 2009; 2(1):59-68.
40. Annie B, Andrew J, Sanders F, Ruge KG, Harding WG, Jiang, Potential implications of interleukin-7 in chronic wound healing, Experimental and Therapeutic Medicine, 2016; 12(1):33-40.
41. Schinkothe T, Bloch W, Schmid A and Annette S, In-vitro secreting profile of human mesenchymal stem cells, Stem cells and development, 2008; 17(1):199-205.
42. Rozita Z, Maryam A and Zarghami N, Involvement of TNF-α in the differential gene expression pattern of CXCR4 on human marrow-derived mesenchymal stem cells, Molecular Biology Reports, 2014; 41(2):1059-66.
43. Fyhrquist F, Metsarinne K and Tikkanen I, Role of angiotensin II in blood pressure regulation and the pathophysiology of cardiovascular disorders, Journal of Human Hypertension, 1995; 9(5):19-24.
44. Claire MR and Neil JS, Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination, Cell Adhesion & Migration, 2010; 4(2):235-40.
45. Layla TG, Thais RF, Patricia S, Carolina BA, Caroline MM, Niels OC, Marimelia AP, Mesenchymal Stem Cell Therapy Modulates the Inflammatory Response in Experimental Traumatic Brain Injury, Neurology Research International, 2011; 20(11):5640-89.
46. Dobroslav K, Ivan B, Ekaterina IT, Milena M, Tsvetelina O, Kalina B, and Stanimir K, Secretion of immunoregulatory cytokines by mesenchymal stem cells, World Journal of Stem Cells, 2014; 6(5):552-570.
47. Lubkowska A, Dolegowska B and Banfi G, Growth Factor Content in PRP and their applicability in medicine, Journal of biological regulators and homeostatic agents, 2012; 26(2):3-22.
48. Hideo M, Toshimitsu O, Taisuke W, Masashi S, Kazuhiko N, Hajime O, Koh N, Kohya U, Chen YS, Tomoyuki K, Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF), International Journal of Implant Dentistry, 2016; 2(1):19.
49. Hong BP, Jeong HY, and Kwang HC, Characterization of the cytokine profile of platelet-rich plasma (PRP) and PRP-induced cell proliferation and migration: Up regulation of matrix metalloproteinase-1 and -9 in HaCaT cells, Korean Journal of Haematology, 2011; 46(4):265–273.
50. Jeong WL, Hyun K, Taek KK, Young KC, Kang YC, Ho YC, Byung CC, Jung DY, and Jun HS, Platelet-Rich Plasma: Quantitative Assessment of Growth Factor Levels and Comparative Analysis of Activated and Inactivated Groups, Archives of Plastic Surgery , 2013; 40(5):530–535.
51. Roh YH, Kim W, and Oh JH, Cytokine-release kinetics of platelet-rich plasma according to various activation protocols, Bone & Joint Research, 2016; 5(2):37–45.
52. Rubina A, Ramon G, A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification, Skin Appendage Disorders Guidelines, 2018; 4:18–24.
53. Carola C, Alice R, Brunella G, Erminia M, Loredana P, Giulia M, Elizaveta K, Maurilio M, and Giuseppe F, Platelet-Rich Plasma: The Choice of Activation Method Affects the Release of Bioactive Molecules, BioMed Research International, 2016; 65917-17.
54. Jamie AT, Fern T, Activation of equine platelet-rich plasma: comparison of methods and characterization of equine autologous thrombin, Veterinary surgery, 2012; 41(7):784-94.
55. Kohei I, Ken IF, Eiichi T, Yuji Y, Shugo M, Takuya N, Yuka K, and Yasuyuki I. Hyaluronic acid induces the release of growth factors from platelet-rich plasma, Asia-Pacific Journal of Sports Medicine, Arthroscopy Rehabilitation and Technology, 2016; 4:27–32.
56. Hyunwook M, Hyosun J, Jae KM, Min JK, Seung BL, Won SJ, Sun JL, Hwi YK, Seung SL, Sehwan S, Sunhoo P, A Method for the Activation of Platelet-Rich Plasma via Bead Mill Homogenizer for Mesenchymal Stem Cell Culture, Tissue Engineering Part C: Methods, 2017; 23(8):465-473.
57. Castro FA, Torres A, Cabazas J, Rodriguez A, Combined use of platelet rich plasma and vitamin C positively affects differentiation in vitro to mesodermal lineage of adult adipose equine mesenchymal stem cells, Research in Veterinary Science, 2014; 96(1):95-101.
Statistics
67 Views | 167 Downloads
How to Cite
1.
Khare S, Dal SS, Lingam S, Veeramanikandan V, Balaji P, Hota A, Kannaiyan J. Plate-Rich Plasma and its Utility in Clinical Conditions: A Systematic Review. JDDT [Internet]. 15Feb.2021 [cited 18Apr.2021];11(1-s):186-94. Available from: http://www.jddtonline.info/index.php/jddt/article/view/4721